Press-release for stocks for PFE

symbols : PFE

save search

FDA Roundup: August 15, 2023
Published: 2023-08-15 (Crawled : 20:00) - fda.gov
FNCTF | News | $11.16 -20.84% 130

Communications

| -0.71% | O: 1.51% H: 0.0% C: -1.03%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -25.63% | O: -0.71% H: 1.45% C: 0.97%
fda

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -26.15% | O: -0.11% H: 1.29% C: 0.67%
INCY | $51.72 0.14% 0.14% 1.5M

Health Technology

| -19.96% | O: 0.08% H: 2.08% C: 1.3%
DCPH | $14.6 -0.48% -0.48% 320K

Health Technology

| 13.37% | O: 4.95% H: 2.5% C: 1.18%
pharmaceuticals financial results

North America Kidney Transplant Research Report 2023
Published: 2023-08-08 (Crawled : 22:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K

Health Technology

| 15.65% | O: 1.11% H: 0.53% C: 0.53%
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| -36.78% | O: 3.93% H: 0.0% C: -3.08%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -26.15% | O: -0.11% H: 1.29% C: 0.67%
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| -4.07% | O: -0.07% H: 0.73% C: 0.36%
MDT | $80.38 -1.12% 0.0% 5M

Health Technology

| -3.15% | O: -1.98% H: 1.7% C: 0.81%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -9.87% | O: 0.81% H: 0.0% C: 0.0%
america report kidney research

Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -26.23% | O: 1.93% H: 0.0% C: -2.01%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 42.74% | O: 1.09% H: 1.29% C: 0.91%
update financial results

Women's Health Global Marketplace 2023-2030: Endometriosis Applications Poised for Remarkable Expansion with Relugoliz and Linzagolix Set to Lead the Way
Published: 2023-08-04 (Crawled : 19:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

Health Technology

| Email alert Add to watchlist
health expansion global linzagolix set

Pfizer Reports Second-Quarter 2023 Results
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 1.65% | O: -1.8% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.08% | O: -0.48% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| -17.6% | O: 1.14% H: 0.0% C: -1.36%
results

Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer
Published: 2023-07-31 (Crawled : 21:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.08% | O: -0.48% H: 0.0% C: 0.0%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 37.54% | O: -0.73% H: 2.32% C: 1.3%
protac breast innovation cancer group designation

Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
Published: 2023-07-27 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -29.27% | O: -1.16% H: 0.0% C: 0.0%
research

Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
Published: 2023-07-21 (Crawled : 21:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -28.42% | O: 0.08% H: 1.71% C: 1.63%

Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
Published: 2023-07-19 (Crawled : 22:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.37% | O: 0.28% H: 0.99% C: 0.28%
candidate vaccine publication group

Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
Published: 2023-07-06 (Crawled : 14:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.81% | O: -0.71% H: 0.19% C: -1.57%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 37.48% | O: -2.06% H: 0.0% C: -3.96%
collaboration trial therapeutics

Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
Published: 2023-07-06 (Crawled : 12:00) - globenewswire.com
CRBU | $3.86 -3.02% -3.11% 1.1M

Health Technology

| -2.45% | O: 37.25% H: 22.86% C: 6.07%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.81% | O: -0.71% H: 0.19% C: -1.57%

Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.66 1.65% 1.62% 1.7M

Health Technology

| Email alert Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| Email alert Add to watchlist
NBIX | News 4 | $138.91 -0.84% -0.85% 880K

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 -2.18% 480

Health Technology

| Email alert Add to watchlist
UCBJY | $65.26 -4.38% 5.9K

Manufacturing

| Email alert Add to watchlist
UCBJF | $128.725 -39.66% 750

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| Email alert Add to watchlist
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| Email alert Add to watchlist
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 6.88% 52K

Health Technology

| Email alert Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| Email alert Add to watchlist
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| Email alert Add to watchlist
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| Email alert Add to watchlist
TEVJF | News | $12.37 -24.22% 380

Health Technology

| Email alert Add to watchlist
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| Email alert Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| Email alert Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M

Health Technology

| Email alert Add to watchlist
report business life global therapeutics

FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Published: 2023-06-28 (Crawled : 11:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.73% | O: 0.22% H: 0.11% C: -0.58%
OPK | $1.225 -2.0% -2.04% 6.1M

Health Technology

| -24.7% | O: 24.1% H: 0.97% C: -16.5%
fda treatment growth hormone

FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
Published: 2023-06-27 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -28.65% | O: 0.19% H: 0.11% C: -1.46%
fda application therapy

Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published: 2023-06-27 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| 7.57% | O: -1.1% H: 0.0% C: 0.0%
TAK | News | $13.23 -1.12% 0.0% 920K

Health Technology

| -15.38% | O: -0.95% H: 0.19% C: -0.32%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -28.65% | O: 0.19% H: 0.11% C: -1.46%
NVS | News | $98.35 1.1% 0.0% 2.2M

Health Technology

| -0.65% | O: -0.01% H: 0.16% C: -0.32%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.54% | O: 0.03% H: 0.12% C: -0.24%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| 13.7% | O: -0.91% H: 0.56% C: -0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 63.23% | O: 2.15% H: 1.18% C: 0.43%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -24.39% | O: -0.06% H: 0.46% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| -1.23% | O: -0.21% H: 0.42% C: 0.13%
report business cancer treat global

Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
Published: 2023-06-26 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -31.28% | O: -3.36% H: 0.09% C: -0.34%
obesity update program diabetes

Pfizer Declares Third-Quarter 2023 Dividend
Published: 2023-06-22 (Crawled : 11:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -32.34% | O: 0.1% H: 0.12% C: -0.54%

Global Axial Spondyloarthritis Treatment Market to 2027: Increase in the Number of Approved Biosimilars Fuels the Sector
Published: 2023-06-16 (Crawled : 02:00) - prnewswire.com
UCBJY | $65.26 -4.38% 5.9K

Manufacturing

| 40.25% | O: 1.21% H: 0.0% C: -0.2%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -33.79% | O: 0.28% H: 1.25% C: 0.5%
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -8.59% | O: 0.46% H: 0.31% C: -0.15%
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 62.81% | O: 0.41% H: 0.26% C: -1.77%
BMY | $48.86 -0.27% -0.02% 16M

Health Technology

| -24.25% | O: 0.32% H: 2.1% C: 1.97%
approved treatment global market

Biosimilars Market worth $66.9 billion | MarketsandMarkets
Published: 2023-06-15 (Crawled : 10:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology